PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19012178-3	2008	DG-041 (2,3-dichlorothiophene-5-sulfonic acid, 3-[1-(2,4-dichlorobenzyl)-5-fluoro-3-methyl-1H-indol-7-yl]acryloylamide) is a direct-acting EP3 antagonist currently being evaluated in Phase 2 clinical trials.	3-[1-(2,4-dichlorobenzyl)-5-fluoro-3-methyl-1h-indol-7-yl]acryloylamide	47-118	prostaglandin E receptor 3	Homo sapiens	139-142